Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Secukinumab Meets 5-Year Benchmark for Psoriasis

Michele B. Kaufman, PharmD, BCGP  |  October 6, 2017

In an extension study, nearly half the patients with plaque psoriasis taking secukinumab maintained skin clearance for the five years of the study…

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsPsoriatic Arthritis Tagged with:Ankylosing SpondylitisPsoriasisPsoriatic Arthritissecukinumab

What Price Glory (or, at Least, Getting Your Foot in the Door)?

Gerald Eisenberg  |  October 4, 2017

In many respects, this is the beginning of the golden age of rheumatology. Diagnostic and therapeutic approaches are now available that have radically altered for the better the lives of people with diseases that were considered virtually untreatable just a few years ago. The rheumatologist’s approach to patients with rheumatoid arthritis, the spondyloarthropathies, osteoporosis and…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Capitol HillIllinois Bone and Joint Institute (IBJI)RheumPACRheumPAC donors

Obamacare Sign-Up Challenge: Proving the Law Is Not Dead

Yasmeen Abutaleb  |  October 4, 2017

NOGALES, Arizona (Reuters)—More than two thousand miles away from the healthcare debate in Washington, President Donald Trump’s threats to let Obamacare collapse are sowing confusion about its fate and dampening 2018 enrollment expectations. The uncertainty here in Arizona, echoed in interviews across the country, shows that even though they have not been able to repeal…

Filed under:Legislation & Advocacy Tagged with:Affordable Care Act (ACA)Obamacare collapse

Efficacy Studied Following Accelerated Drug Approvals

Michele B. Kaufman, PharmD, BCGP  |  October 2, 2017

In recent years, the number of drugs to receive accelerated FDA approval has increased. A new study examined whether these drugs have demonstrated efficacy in post-approval trials…

Filed under:Drug Updates Tagged with:acceleratedFDAFDA approvalU.S. Food and Drug Administration (FDA)

Adalimumab + Methotrexate Effective for Uveitis in JIA

Lara C. Pullen, PhD  |  October 2, 2017

Research has found that taking adalimumab plus methotrexate is effective for patients with juvenile idiopathic arthritis-associated uveitis. However, these patients may also experience an increased incidence of adverse and serious adverse events compared with those taking only methotrexate…

Filed under:ConditionsOther Rheumatic ConditionsPediatric Conditions Tagged with:adalimumabJIAJuvenile Arthritis (JIA)MethotrexatePediatricPediatric RheumatologyUveitis

Help Pediatric Patients Overcome Pain & Anxiety

Karen Appold  |  September 29, 2017

Pediatric rheumatology patients present unique challenges. According to Kyla Driest, MD, MEd, using age and temperament appropriate methods, such as distraction or icing, may help children manage pain and ease anxiety…

Filed under:ConditionsPediatric ConditionsPractice Support Tagged with:Childrenpatient carepatient communicationPediatricPediatric Rheumatology

Sequential Therapy May Reduce Hip Fracture Risk; Plus New Biosimilar Available in Canada

Michele B. Kaufman, PharmD, BCGP  |  September 27, 2017

Patients who receive abaloparatide and switch to alendronate have a statistically significant reduction in fracture risk through 3.5 years, according to a new study…

Filed under:Biologics/DMARDsDrug Updates Tagged with:abaloparatidealendronateBiologics & Biosimilarsetanerceptetanercept-szzsFractureshiphip fracturehip fracture risk

AMP RA/Lupus Network Shares Its Progress

Lara C. Pullen, PhD  |  September 26, 2017

Researchers from the AMP RA/Lupus Network came together in June at the annual FOCIS meeting to share their progress as they perform a systematic molecular deconstruction of human diseases…

Filed under:ConditionsRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:Accelerating Medicines PartnershipLupusNational Institutes of Health (NIH)Rheumatoid Arthritis (RA)systemic lupus erythematosus (SLE)

Republican Bill to Repeal Obamacare Teeters on Edge of Collapse

Susan Cornwell & Richard Cowan  |  September 25, 2017

WASHINGTON (Reuters)—The latest Republican effort to repeal former U.S. President Barack Obama’s signature healthcare law faced possible defeat this week as several senators in the party voiced concerns about the bill under consideration. The U.S. Senate is up against a Saturday deadline for deciding the fate of the 2010 Affordable Care Act, popularly known as…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Affordable Care Act (ACA)Health InsuranceObamacareObamacare repealSenate healthcare billU.S. Senate

Lupus Incidence, Prevalence Differ by Race

Loraine L. Janeczko  |  September 24, 2017

NEW YORK (Reuters Health)—Racial and ethnic disparities in systemic lupus erythematosus (SLE) incidence and prevalence are considerable, according to two new studies of data from California and Manhattan. “The most important finding of the population-based California and New York registries is the confirmation of the racial and ethnic disparities of SLE, with the highest incidence…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:Lupussystemic lupus erythematosus (SLE)

  • « Previous Page
  • 1
  • …
  • 172
  • 173
  • 174
  • 175
  • 176
  • …
  • 323
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences